Table 3 Summary of best overall response among response evaluable patients
| Â | Number (%) of subjects (N=36) |
|---|---|
Complete response (CR) | 0 |
Partial response (PR) | 4 (11.1) |
Stable for 10 weeks/no response | 7 (19.4) |
Objective progression | 19 (52.8) |
Indeterminate | 6 (16.7) |